✦ LIBER ✦

Hypofractionated Chemoradiation Therapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally-Advanced Pancreatic Cancer

✍ Scribed by Romeo, A.; Parisi, E.; Passardi, A.; Bellia, S.; Arpa, D.; Ghigi, G.; Neri, E.; Sarnelli, A.; Tesei, A.; Polico, R.

Book ID: 122276757
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 46 KB
Volume: 87
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2013.06.807

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant chemoradiation with Gemcitab

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer

✍ Daniel Habermehl, Kerstin Kessel, Thomas Welzel, Holger Hof… 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 359 KB

Induction Gemcitabine Plus Concurrent Ge

Induction Gemcitabine Plus Concurrent Gemcitabine and Radiotherapy for Locally Advanced Unresectable or Resected Pancreatic Cancer

✍ Youl, M.; Hashem, S.; Brade, A.; Cummings, B.; Dawson, L.A.; Gallinger, S.; Hedl 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 461 KB

Resectability After Concurrent Gemcitabi

Resectability After Concurrent Gemcitabine-Based Chemoradiation Therapy for Patients With Locally-Advanced Pancreatic Cancer

✍ Skamene, S.; Niazi, T.; Kopek, N.; Vanounou, T.; Vuong, T. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Radiation Therapy With Full-Dose Gemcita

Radiation Therapy With Full-Dose Gemcitabine and Oxaliplatin for Unresectable Pancreatic Cancer

✍ Klaudia U. Hunter; Felix Y. Feng; Kent A. Griffith; Isaac R. Francis; Theodore S 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Induction chemotherapy selects patients

Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy

✍ Sunil Krishnan; Vishal Rana; Nora A. Janjan; Gauri R. Varadhachary; James L. Abb 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB

## Abstract ## BACKGROUND. The current study was conducted to determine whether there were differences in outcome for patients with unresectable locally advanced pancreatic cancer (LAPC) who received treatment with chemoradiation therapy (CR) versus induction chemotherapy followed by CR (CCR). ##

Bevacizumab plus gemcitabine and oxalipl

Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial

✍ David Fogelman; Mehrdad Jafari; Gauri R. Varadhachary; Henry Xiong; Susie Bulloc 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 216 KB